NO20053575L - Metallprotease proteiner - Google Patents

Metallprotease proteiner

Info

Publication number
NO20053575L
NO20053575L NO20053575A NO20053575A NO20053575L NO 20053575 L NO20053575 L NO 20053575L NO 20053575 A NO20053575 A NO 20053575A NO 20053575 A NO20053575 A NO 20053575A NO 20053575 L NO20053575 L NO 20053575L
Authority
NO
Norway
Prior art keywords
proteins
protease proteins
metal protease
insp005b
insp005a
Prior art date
Application number
NO20053575A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053575D0 (no
Inventor
Ursula Boschert
Yolande Chvatchko
Christine Power
Richard Joseph Fagan
Christopher Benjamin Phelps
Richard James Mitter
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20053575D0 publication Critical patent/NO20053575D0/no
Publication of NO20053575L publication Critical patent/NO20053575L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
NO20053575A 2002-12-23 2005-07-21 Metallprotease proteiner NO20053575L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0230006.9A GB0230006D0 (en) 2002-12-23 2002-12-23 Proteins
PCT/GB2003/005664 WO2004056983A2 (fr) 2002-12-23 2003-12-23 Proteines de metalloprotease

Publications (2)

Publication Number Publication Date
NO20053575D0 NO20053575D0 (no) 2005-07-21
NO20053575L true NO20053575L (no) 2005-09-23

Family

ID=9950313

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053575A NO20053575L (no) 2002-12-23 2005-07-21 Metallprotease proteiner

Country Status (11)

Country Link
US (1) US7557079B2 (fr)
EP (1) EP1583825B1 (fr)
JP (1) JP5053516B2 (fr)
AT (1) ATE526400T1 (fr)
AU (1) AU2003290342B2 (fr)
CA (1) CA2510066A1 (fr)
ES (1) ES2374392T3 (fr)
GB (1) GB0230006D0 (fr)
IL (1) IL169256A (fr)
NO (1) NO20053575L (fr)
WO (1) WO2004056983A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100183617A1 (en) * 2005-02-23 2010-07-22 University Of Virginia Patent Foundation Compositions and methods for regulating sas1r
GB0921001D0 (en) 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
CN109957557B (zh) * 2017-12-26 2023-01-06 广州市锐博生物科技有限公司 Dna聚合酶及其制备方法
CN114032252B (zh) * 2021-11-01 2022-04-22 武汉爱博泰克生物科技有限公司 一种重组状态人源mmp-7蛋白的表达方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420490A1 (fr) 2000-08-23 2002-02-28 Applera Corporation Proteines proteasiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines proteasiques humaines, et utilisations correspondantes
EP1362108A2 (fr) * 2001-02-20 2003-11-19 Lexicon Genetics Incorporated Nouvelle protease humaine et polynucleotides codant pour ladite protease
CA2459140A1 (fr) 2001-09-14 2003-03-27 Incyte Genomics, Inc. Molecules de maintenance et de modification de proteines

Also Published As

Publication number Publication date
IL169256A0 (en) 2007-07-04
WO2004056983A2 (fr) 2004-07-08
GB0230006D0 (en) 2003-01-29
ES2374392T3 (es) 2012-02-16
ATE526400T1 (de) 2011-10-15
JP2006516888A (ja) 2006-07-13
AU2003290342A1 (en) 2004-07-14
WO2004056983A3 (fr) 2006-02-09
CA2510066A1 (fr) 2004-07-08
EP1583825A2 (fr) 2005-10-12
IL169256A (en) 2010-11-30
EP1583825B1 (fr) 2011-09-28
US7557079B2 (en) 2009-07-07
US20060252117A1 (en) 2006-11-09
AU2003290342B2 (en) 2009-09-24
JP5053516B2 (ja) 2012-10-17
NO20053575D0 (no) 2005-07-21

Similar Documents

Publication Publication Date Title
NO20052956D0 (no) Defensinprotiner
WO2006046073A3 (fr) Proteine du type c1q
WO2003055912A3 (fr) Proteines secretees
NO20053575D0 (no) Metallprotease proteiner
WO2004096856A3 (fr) Famille de proteines secretees
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
UA93658C2 (en) Cell surface glycoprotein
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon
WO2004053117A3 (fr) Serine protease
WO2003054178A3 (fr) Proteines de metalloprotease
WO2002033058A3 (fr) Proteases a cysteine
EA200501843A1 (ru) Tnf-подобный секретируемый белок
WO2004035626A8 (fr) Membres de la famille des alpha-macroglobulines
WO2007049062A3 (fr) Protéines contenant des domaines vwfa
WO2002062976A3 (fr) Proteases a serine
WO2004101618A3 (fr) Proteines associees au recepteur de progestine yol002c-cgi-45
WO2004041861A3 (fr) Element de la famille des alpha macroglobulines
WO2004026905A3 (fr) Proteines de transport/canal
WO2002062845A3 (fr) Molecules d'adhesion
WO2004000882A3 (fr) Proteines
WO2002044382A8 (fr) Proteines de cytokine
WO2004011648A3 (fr) Cytochromes p450
WO2002088341A3 (fr) Proteines p450
WO2003089469A3 (fr) Proteines-canaux cationiques
WO2004024762A3 (fr) Proteine de type il-8

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application